EC
EMCORE CORP (EMKR)·Q1 2024 Earnings Summary
Executive Summary
- Q1 2024 revenue was $24.1M with GAAP gross margin 25% and non-GAAP gross margin 29%; Adjusted EBITDA was $(1.7)M, and non-GAAP continuing EPS was $(0.03) .
- Sequentially, revenue fell from $26.8M in Q4 2023 primarily due to export license delays and a defective PCB lot; management maintained margins and reduced internally funded R&D (IRAD) .
- Guidance: Q2 2024 revenue expected at $23–$25M, and management “expects a return to quarterly top-line growth in the June quarter” (Q3) with new programs and integration progress .
- Street consensus (S&P Global) was unavailable for EMKR this quarter; note comparisons to estimates cannot be made—portfolio managers should focus on company guidance and execution drivers (export licensing, program timing, backlog/bookings) [SpgiEstimatesError].
- Stock narrative catalysts: revenue miss vs prior Q4 guidance ($26–$28M), stable margins, wafer fab sale timing, backlog expected to strengthen and book-to-bill >1 in Q2, but extended delivery schedules push near-term shipments .
What Went Well and What Went Wrong
What Went Well
- Non-GAAP gross margin held at 29% despite lower revenue, supported by favorable mix and improved overhead absorption at Tinley Park and Concord .
- IRAD down by ~$0.6M sequentially; management expects continued reductions via customer-funded NRE (target ≥ $7M in calendar 2024) .
- Backlog remained sizable (~$51M at quarter-end) with expected recovery in Q2; book-to-bill anticipated significantly >1.0 in the March quarter .
What Went Wrong
- Revenue declined to $24.1M from $26.8M due to delayed export licenses (
$0.75M pushouts) and defective PCB lot during holiday supplier shutdown; some engineering work ($0.8M NRE) did not count as revenue in the quarter . - Book-to-bill <1.0 in Q1 given shortened holiday season and order timing; customer-requested ship dates extend out, dampening near-term shipments .
- Cash decreased to $21.2M (from $26.7M in Q4) driven by negative EBITDA, discontinued ops, legal settlement, debt reduction, severance, and working capital; management’s “comfort level” is ~$20M cash but operating below it is manageable .
Financial Results
Quarterly Trend (oldest → newest)
Q1 2024 vs Prior Year (YoY)
Notes: Q1 2023 is pre-restructuring; discontinued ops were included in consolidated results. EMCORE began reporting legacy businesses as discontinued ops in Q4 2023 .
KPIs and Operational Metrics
Site-Level Commentary (qualitative)
- Tinley Park: continuous steady growth, improved absorption .
- Concord: improved absorption; ERP/MES integration planned; footprint reduction underway .
- Budd Lake: near-term revenue headwind from TI-MU (TAIMU) program changes; MMS anticipated to replace revenue as production starts in early 2024 .
- Alhambra: consolidating to a single building post wafer fab sale; optical component assembly consolidation .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Chicago, Concord, and Alhambra showed increased revenue over the September quarter, but not enough to offset the lower shipments out of Budd Lake… we continued to achieve a solid gross margin and substantially reduced internally-funded R&D.” — Jeff Rittichier, CEO .
- “Gross margin held up at 29% in 1Q despite the lower revenue, contributing to the favorable margin was improved fixed overhead absorption in Tinley Park and Concord and an overall favorable mix.” — Tom Minichiello, CFO .
- “At quarter's end, backlog… approximately $51 million… we expect to fully resolve [the reduction] in the March quarter.” — Jeff Rittichier, CEO .
- “The March quarter is expected to be flat compared to December with a range of $23 million to $25 million.” — Jeff Rittichier, CEO .
- “We like $20 million as a good comfort level [for cash], but we are operating below that, which is doable.” — Tom Minichiello, CFO .
Q&A Highlights
- Budd Lake revenue replacement: TAIMU near-term gap to be backfilled by MMS as production starts early ’24; expect resumption of growth by June quarter (Q3) .
- Wafer fab sale: Confidence reiterated; exclusivity lost due to delays; multiple bidders; aiming to close as soon as possible .
- Cash burn: Q2 (March) cash use likely within a $3–$5M range, upper end more likely, with efforts to improve working capital (esp. Concord inventory) .
- Cash comfort: ~$20M preferred; operating below is manageable if business goals met .
- Bookings cadence: Book-to-bill expected >1.0 in Q2; backlog could surprise positively, but delivery timing extends out, limiting near-term shipments .
Estimates Context
- S&P Global consensus estimates for EMKR were unavailable due to missing CIQ mapping; therefore, comparisons vs Street EPS and revenue estimates cannot be made this quarter [SpgiEstimatesError].
- Use company guidance ($23–$25M for Q2) and margin commentary (“similar margins”) as the anchor for near-term expectations .
Key Takeaways for Investors
- Margin durability amid revenue pressure: Non-GAAP gross margin held at 29%, supported by mix and absorption; expect similar margin in Q2 even as shipments are pushed out .
- Near-term growth pause, bookings strength: Extended delivery schedules will dampen Q2 shipments; book-to-bill expected significantly >1.0 suggests backlog recovery into Q3 .
- Program rebalancing post-TAIMU: Management cites high-confidence offsets and MMS ramp to replace Budd Lake revenue; monitor execution and timing .
- Cash discipline and OpEx control: Cash decreased to $21.2M; management reducing IRAD and leveraging NRE to lower OpEx; watch working capital actions and litigation/severance tail-offs .
- Strategic simplification: Wafer fab divestiture progressing; ERP/MES and footprint consolidation are medium-term margin and efficiency levers .
- Trading implications: Near-term prints may reflect shipment timing rather than demand; reaction likely tied to wafer fab sale closure, bookings momentum, and confirmation of Q3 top-line growth path .
- Medium-term thesis: A pure-play inertial navigation platform with improving operating leverage, customer-funded R&D, and backlog growth should expand margins as volume ramps, contingent on supply chain/export licensing timing and program milestones .